Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Sarcoma × Sorafenib × Clear all

Phase

Status

Sponsor Class

OTHER 9 NIH 4 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Osteosarcoma 2 Stomach Neoplasms 1 Sarcoma 1 Prostatic Neoplasms 1 Lung Neoplasms 1 Hepatoblastoma 1 Fibrolamellar hepatocellular carcinoma 1 Esophageal Neoplasms 1 Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Medullary 1 Carcinoma, Hepatocellular 1 Adenocarcinoma Of Esophagus 1

Interventions

Ifosfamide 18 Doxorubicin 18 Filgrastim 16 Radiotherapy 12 Vincristine 10 Cyclophosphamide 10 Cisplatin 9 Etoposide 8 Trabectedin 7 Granulocyte Colony-Stimulating Factor 7 Gene Expression Profiling 7 Polymerase Chain Reaction 6 Dactinomycin 6 sargramostim 5 etoposide phosphate 5 Paclitaxel 5 Mesna 4 Chemotherapy, Adjuvant 4 Brachytherapy 4 pegfilgrastim 3 Topotecan 3 Microarray Analysis 3 Irinotecan 3 Immunohistochemistry 3 Gemcitabine 3 Dexrazoxane 3 Base Sequence 3 olaparib 2 brostallicin 2 Surgical Procedures, Operative 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01804374 2015-06-17

SERIO

Italian Sarcoma Group

Phase 2 Completed

Sarcoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡